Hemoperfusion Efferon СT for the Extremely Severe Form of COVID-19

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

February 28, 2022

Study Completion Date

December 1, 2023

Conditions
COVID-19
Interventions
DEVICE

Efferon CT therapy

Efferon CT is a cylindrical body made of polycarbonate, filled with spherical granules of polymer hemocompatible macroporous styrene-divinylbenzene copolymer of super cross- linked type and isotonic sodium chloride solution. The device is manufactured according to TU 32.50.50-001-12264678-2018, has passed the necessary tests and is registered in Russia as a medical product RZN 2019/8886. Hemoperfusion procedures were performed using the Efferon CT device no later than 6 hours after the start of invasive ventilation. Hemosorption was performed twice within 12 hours, with an interval of 24 hours between hemoperfusion.

Trial Locations (1)

Unknown

Alexey Yakovlev, Nizhny Novgorod

All Listed Sponsors
lead

Efferon JSC

INDUSTRY

NCT06402279 - Hemoperfusion Efferon СT for the Extremely Severe Form of COVID-19 | Biotech Hunter | Biotech Hunter